These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6158667)

  • 1. [Stimulation of endogenous TSH secretion and endocrine orbitopathy].
    Wuttke H; Schlieter D
    Med Klin; 1980 Aug; 75(18):658-62. PubMed ID: 6158667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of thyroxine upon prevention of recurrence of Graves' disease treated with antithyroid drugs].
    Wu G; Jie Y; Situ Y
    Zhonghua Yi Xue Za Zhi; 2001 Mar; 81(5):274-5. PubMed ID: 11798886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased secretion of gonadotropins in a patient with Graves' disease.
    Hakamata M; Itoh M; Sudo Y; Katada E; Miyata N
    Exp Clin Endocrinol Diabetes; 1996; 104(1):85-8. PubMed ID: 8750576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Graves' disease: effects of the administration of L-thyroxine associated with methimazole as a single daily dose.
    Perozim LM; Lima N; Knobel M; Cavaliere H; Medeiros-Neto G
    Eur J Med; 1993 Feb; 2(2):70-4. PubMed ID: 8258020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valuable predictive features of relapse of Graves' disease after antithyroid drug treatment.
    Liu X; Shi B; Li H
    Ann Endocrinol (Paris); 2015 Dec; 76(6):679-83. PubMed ID: 26514949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methimazole protection against oxidative stress induced by hyperthyroidism in Graves disease.
    Sewerynek J; Wiktorska J; Nowak D; Lewinski A
    Endocr Regul; 2000 Jun; 34(2):83-9. PubMed ID: 10911409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
    Ward L; Huot C; Lambert R; Deal C; Collu R; Van Vliet G
    Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy.
    Antonelli A; Rotondi M; Fallahi P; Romagnani P; Ferrari SM; Barani L; Ferrannini E; Serio M
    Clin Endocrinol (Oxf); 2006 Feb; 64(2):189-95. PubMed ID: 16430719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term antithyroid drug therapy for the thyrotoxicosis of Graves's disease.
    Greer MA; Kammer H; Bouma DJ
    N Engl J Med; 1977 Jul; 297(4):173-6. PubMed ID: 69269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and significance of steatorrhea in patients with active Graves' disease.
    Goswami R; Tandon RK; Dudha A; Kochupillai N
    Am J Gastroenterol; 1998 Jul; 93(7):1122-5. PubMed ID: 9672342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
    Tsai WC; Pei D; Wang TF; Wu DA; Li JC; Wei CL; Lee CH; Chen SP; Kuo SW
    Clin Endocrinol (Oxf); 2005 May; 62(5):521-4. PubMed ID: 15853819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The balance shift in Th1/Th2 related IL-12/IL-5 cytokines in Graves' disease during methimazole therapy.
    Molnár I
    Autoimmunity; 2007 Feb; 40(1):31-7. PubMed ID: 17364495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutropenia Occurs More Often Under Carbimazole than Under Methimazole Treatment in Pediatric Graves' Disease Patients.
    Schempp V; Cebeci AN; Reinauer C; Woelfle J; Dörr HG; Roosen MT; Gohlke J; Gohlke B
    Thyroid; 2024 Jun; 34(6):735-743. PubMed ID: 38613811
    [No Abstract]   [Full Text] [Related]  

  • 15. Effective methimazole dose for childhood Graves' disease and use of free triiodothyronine combined with concurrent thyroid-stimulating hormone level to identify mild hyperthyroidism and delayed pituitary recovery.
    Slyper AH; Wyatt D; Boudreau C
    J Pediatr Endocrinol Metab; 2005 Jun; 18(6):597-602. PubMed ID: 16042328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppression of Graves' hyperthyroidism--still an elusive goal.
    Wiersinga WM
    N Engl J Med; 1996 Jan; 334(4):265-6. PubMed ID: 8532007
    [No Abstract]   [Full Text] [Related]  

  • 17. Antithyroid drugs as a factor influencing the outcome of radioiodine therapy in Graves' disease and toxic nodular goitre?
    Körber C; Schneider P; Körber-Hafner N; Hänscheid H; Reiners C
    Eur J Nucl Med; 2001 Sep; 28(9):1360-4. PubMed ID: 11585295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical therapy of Graves' disease: effect on remission rates of methimazole alone and in combination with triiodothyronine.
    Raber W; Kmen E; Waldhäusl W; Vierhapper H
    Eur J Endocrinol; 2000 Feb; 142(2):117-24. PubMed ID: 10664518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacology and dosage of thyrostatic drugs].
    Passath A; Leb G; Warnkross H
    Acta Med Austriaca; 1987; 14(3-4):72-4. PubMed ID: 2447738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of the results of treatment of Graves' disease by synthetic antithyroid drugs].
    Fischer D; Poncin J; Dunet R; Dry J; Thomas M
    Sem Hop; 1977 Oct 9-16; 53(34-35):1843-9. PubMed ID: 73224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.